Potential blood biomarkers for stroke

CM Laborde, L Mourino–Alvarez… - Expert review of …, 2012 - Taylor & Francis
Stroke is one of the most common causes of death worldwide and a major cause of acquired
disability in adults. Despite advances in research during the last decade, prevention and …

[HTML][HTML] Small vessel disease-related dementia: an invalid neurovascular coupling?

R Moretti, P Caruso - International Journal of Molecular Sciences, 2020 - mdpi.com
The arteriosclerosis-dependent alteration of brain perfusion is one of the major determinants
in small vessel disease, since small vessels have a pivotal role in the brain's autoregulation …

[HTML][HTML] Blood-based proteomics for personalized medicine: examples from neurodegenerative disease

IL Goldknopf - Expert Review of Proteomics, 2008 - Taylor & Francis
In 1927, the great Danish physicist Niels Bohr proposed that some natural phenomena can
only be completely understood by combining two or more experimental approaches that …

Proteomics in neurodegeneration–disease driven approaches

T Schulenborg, O Schmidt, A Van Hall… - Journal of neural …, 2006 - Springer
Proteins as a product from genetic information execute and determine how development,
growth, aging and disease factors are orchestrated within the lifetime of an organism …

Biological and methodical challenges of blood-based proteomics in the field of neurological research

S Lista, F Faltraco, H Hampel - Progress in neurobiology, 2013 - Elsevier
Biomarker discovery is an application of major importance in today's proteomic research.
There is an urgent need for suitable biomarkers to improve diagnostic tools and treatment in …

Protein markers of ischemic insult in brain endothelial cells identified using 2D gel electrophoresis and ICAT-based quantitative proteomics

AS Haqqani, J Kelly, E Baumann… - Journal of proteome …, 2007 - ACS Publications
The blood− brain barrier (BBB) is formed by endothelial cells of cerebral microvessels
sealed by tight junctions. Ischemic brain injury is known to initiate a series of biochemical …

Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid

AM Wojtas, EB Dammer, Q Guo, L Ping… - Alzheimer's & …, 2024 - Wiley Online Library
INTRODUCTION Cerebrovascular dysfunction is a pathological hallmark of Alzheimer's
disease (AD). Nevertheless, detecting cerebrovascular changes within bulk tissues has …

Proteomic characterization of the dynamics of ischemic stroke in mice

RF Gu, T Fang, A Nelson, S Gyoneva… - Journal of Proteome …, 2021 - ACS Publications
Novel therapies and biomarkers are needed for the treatment of acute ischemic stroke (AIS).
This study aimed to provide comprehensive insights into the dynamic proteome changes …

[HTML][HTML] Advances in proteomics allow insights into neuronal proteomes

E Fingleton, Y Li, KW Roche - Frontiers in Molecular Neuroscience, 2021 - frontiersin.org
Protein–protein interaction networks and signaling complexes are essential for normal brain
function and are often dysregulated in neurological disorders. Nevertheless, unraveling …

Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke

BQ Zhao, E Tejima, EH Lo - Stroke, 2007 - Am Heart Assoc
Matrix metalloproteinases (MMPs) mediate tissue injury during acute stroke. Clinical data
show that elevated MMPs in plasma of stroke patients may correlate with outcomes …